- Article
Antagonizing Activin A/p15INK4b Signaling as Therapeutic Strategy for Liver Disease
- Sowmya Mekala,
- Ravi Rai,
- Samantha Loretta Reed,
- Bill Bowen,
- George K. Michalopoulos,
- Joseph Locker,
- Reben Raeman and
- Michael Oertel
Background/Aim: Activin A is involved in the pathogenesis of human liver diseases, but its therapeutic targeting is not fully explored. Here, we tested the effect of novel, highly specific small-molecule-based activin A antagonists (NUCC-474/555) in...

